罗格列酮对白血病K562细胞的诱导凋亡作用及其作用机制  

Apoptosis inducing effect of peroxisome proliferator-activated receptor V agonist on K562 cells and its mechanism

在线阅读下载全文

作  者:胡婷[1] 徐妍[1] 王春芝[1] 刘加军[1] 肖若芝[1] 林东军[1] 潘祥林[2] 

机构地区:[1]中山大学附属第三医院血液科,广州510630 [2]山东大学第二医院血液

出  处:《国际肿瘤学杂志》2008年第11期874-877,共4页Journal of International Oncology

基  金:国家自然科学基金资助项目(30570786);教育部新世纪优秀人才支持计划资助项目(NCET-06-0721)

摘  要:目的探讨过氧化物酶体增殖物激活受体γ(PPARγ)激动剂罗格列酮(rosiglitazone,RGZ)对白血病K562细胞的诱导凋亡作用及其作用机制。方法以不同浓度的RGZ(20~80μmoL/L)作用于体外培养的K562细胞0、24、48、72h,应用噻唑蓝法检测细胞生长抑制率,用膜联蛋白V-碘化丙啶双染法检测细胞凋亡,并对细胞凋亡前后P53蛋白的表达水平及Caspse-3活性进行检测。结果40μmol/L以上的RGZ可显著抑制细胞生长及诱导细胞发生凋亡,呈现出明显的量效与时效关系,在细胞凋亡的同时,P53蛋白的表达水平及Caspse-3活性均明显升高。结论40μmol/L以上的RGZ能显著抑制K562细胞的生长并诱导细胞发生凋亡,升高半胱天冬蛋白酶(Caspse)-3活性,上调促凋亡蛋白P53的表达水平是RGZ诱导K562细胞发生凋亡的重要作用机制之一。Objective To investigate the apoptosis inducing effect of peroxisome proliferator-activated receptor γ (PPARγ) agonist on leukemic K562 cells and its mechanisms of action. Methods K562 cells in culture medium in vitro were given different concentrations of PPARs, agonist rosiglitazone (RGZ) (20-80 μmol/L) for 0,24,48 and 72 h. The inhibitory rate of the cells were measured by MTT assay, cell apoptosis was detected by Annexin V/PI staining, and the expression of P53 protein as well as the activity of caspase-3 were also detected. Results RGZ ( over 40 μmol/L) could inhibit the growth of K562 cells and cause apoptosis remarkably, the suppression was both in time-and dose-dependent manner. The expression of P53 protein was upregulated and the activity of caspase-3 was increased concomitantly after the cells were treated by RGZ. Conclusion PPARy agonist RGZ( over 40 μmol/L) can induce apoptosis on K562 cells significantly, upregu- lation the expression of P53 protein as well as increasing caspase-3 activity may be one of its most important mechamisms.

关 键 词:过氧化物酶体增殖物激活受体 细胞凋亡 白血病 

分 类 号:R285[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象